Key oncogenetic EGFR alterations upon which NSCLC tumours become addicted to EGFR signals include somatic mutations in the EGFR gene clustered around the periphery of the catalytic adenosine triphosphate (ATP)-binding cleft in EGFR’s kinase domain (Figure 1A). Here, EGFR is linked to neoplasm.